XML 77 R60.htm IDEA: XBRL DOCUMENT v3.25.0.1
Medytox Settlement Agreements (Details) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Feb. 18, 2021
Feb. 28, 2021
Mar. 31, 2023
Mar. 31, 2022
Sep. 30, 2021
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Loss Contingencies [Line Items]                
Settlement agreement, manufacturing license period (months) 21 months              
Loss contingency accrual           $ 0    
Payments for legal settlements           $ 0 $ 5,000,000 $ 15,000,000
Common stock, par value (in dollars per share)           $ 0.00001 $ 0.00001  
Share issuance agreement, percentage of share dispose per year, initial period 25.00%              
Share issuance agreement, percentage of share dispose per year, period two 50.00%              
Share issuance agreement, percentage of share dispose per year, period three 75.00%              
Accrued royalties under the medytox settlement agreements           $ 4,743,000 $ 3,657,000  
Common Stock                
Loss Contingencies [Line Items]                
Issuance of common stock in connection with litigation settlement (in shares) 6,762,652   6,762,652          
Intellectual Property Disputes, Jeuveau                
Loss Contingencies [Line Items]                
Loss contingency accrual $ 35,000,000 $ 35,000,000            
Settlement agreement, payment terms (in years) 2 years 2 years            
Payments for legal settlements     $ 5,000,000 $ 15,000,000 $ 15,000,000      
Common stock, par value (in dollars per share) $ 0.00001